Anti-diabetic and Anti-inflammatory activities of Hydroalcoholic Flower Extract of Sphagneticola trilobata

Diabetes mellitus and inflammation are among the most prevalent chronic disorders worldwide, creating a growing need for safer and more effective therapeutic agents. Medicinal plants have gained significant attention due to their rich phytochemical composition and broad pharmacological activities. The present study aimed to evaluate the in vitro antidiabetic and anti-inflammatory activities of the hydroalcoholic flower extract of Sphagneticola trilobata. Fresh flowers were collected, shade-dried, and extracted using 70% ethanol by the Soxhlet extraction method. The obtained extract showed a percentage yield of 8.24% and was subjected to preliminary phytochemical screening, which confirmed the presence of flavonoids, glycosides, tannins, triterpenes, steroids, carbohydrates, and reducing sugars. The anti-inflammatory activity was assessed by the nitric oxide (NO) inhibition assay using RAW 264.7 macrophage cells, while the antidiabetic activity was evaluated by the glucose utilization assay using HepG2 cell lines, with metformin serving as the standard drug. The extract exhibited dose-dependent anti-inflammatory activity, achieving 69.90% NO inhibition at 100 µg/mL, and demonstrated significant enhancement of glucose utilization, reaching 166.19% of control at 100µg/mL. These findings indicate promising anti-inflammatory and antidiabetic potential, which may be attributed to the synergistic action of the phytoconstituents present in the extract.

References

[1]American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1)–S350. International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels: International Diabetes Federation; 2025. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177–185. Etxeberria U, de la Garza AL, Campión J, Martínez JA, Milagro FI. Antidiabetic effects of natural plant extracts via AMPK activation. Mini Rev Med Chem. 2012;12(7):698–706. Bohlmann F, Zdero C. Terpenoids and flavonoids from Wedelia species. Phytochemistry. 1982;21:2543–2549. Lim TK. Edible Medicinal and Non-Medicinal Plants. Vol. 7. Dordrecht: Springer; 2013. Meena AK, Rao MM, Panda P, Renu. Evaluation of anti-inflammatory activity of Wedelia trilobata in experimental models. Pharmacognosy Research. 2011;3(3):174–177. Mandal SC, et al. Antibacterial activity of Wedelia trilobata extracts. Indian Journal of Pharmaceutical Sciences. 2005;67:148–150. Karmegam N, et al. Hepatoprotective activity of ethanolic extract of Wedelia trilobata against CCl₄-induced hepatotoxicity in rats. Journal of Ethnopharmacology. 2008;116:204–210. Sureshkumar SV, Mishra SH. Evaluation of analgesic activity of Wedelia trilobata. Indian Drugs. 2007;44:475–478. Kanikaram S, et al. Quantitative estimation of phytochemicals, antidiabetic and antioxidant activities of crude extracts of Sphagneticola trilobata (L.) and Adhatoda vasica Linn. International Journal of Pharmaceutical Sciences and Research. 2018;9(8):3276–3283. Lim TK. Edible Medicinal and Non-Medicinal Plants. Vol. 7. Dordrecht: Springer; 2013. Bohlmann F, Zdero C. Terpenoids and flavonoids from Wedelia species. Phytochemistry. 1982;21:2543–2549. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177–185. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131–138. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. Etxeberria U, de la Garza AL, Campión J, Martínez JA, Milagro FI. Antidiabetic effects of natural plant extracts via AMPK activation. Mini Rev Med Chem. 2012;12(7):698–706. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1)–S350. Meena AK, Rao MM, Panda P, et al. Evaluation of anti-inflammatory activity of Wedelia trilobata in experimental models. Pharmacognosy Research. 2011;3(3):174–177. Kanikaram S, et al. Quantitative estimation of phytochemicals, antidiabetic and antioxidant activities of crude extracts of Sphagneticola trilobata (L.) and Adhatoda vasica Linn. Int J Pharm Sci Res. 2018;9(8):3276–3283. Karmegam N, et al. Hepatoprotective activity of Wedelia trilobata against carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol. 2008;116:204–210. Mandal SC, et al. Antimicrobial activity of Wedelia trilobata extracts. Indian J Pharm Sci. 2005;67:148–150.

Authors (6)

Dr Gomathi Periyasamy

Guru Nanak Institutions Techni...Guru Nanak Institutions Technical CampusGuru Nanak Institutions Technical CampusGuru Nanak Institutions Technical Campus

View all publications →